Home » Texas Children’s Hospital researchers awarded more than $290,000 from Simmons Family Foundation for joint collaboration projects
The Virginia and L.E. Simmons Family Foundation provided a total of $635,000 to support the Collaborative Research Fund program. This five-year, $3 million initiative, provides funding to support teams of collaborators from Texas Children’s Hospital, Rice University and The Methodist Hospital Research Institute (TMHRI) as they discover new ways to diagnose and treat diseases.
HOUSTON — (April 3, 2012) — This year at the 2012 Collaborative Research Awards Luncheon held on Feb. 17, the Virginia and L.E. Simmons Family Foundation provided a total of $635,000 to support the Collaborative Research Fund program. This five-year, $3 million initiative, provides funding to support teams of collaborators from Texas Children’s Hospital, Rice University and The Methodist Hospital Research Institute (TMHRI) as they discover new ways to diagnose and treat diseases.
Of the four projects funded this year, three of the collaborative teams included Texas Children’s Hospital researchers. Successful initial findings will ideally lead the researchers to pursue further funding from the National Science Foundation, the National Institutes of Health and other organizations.
The three team projects with Texas Children’s collaborators include:
“Potent organometallic inhibitors of Signal Transducer and Activator of Transcription 3 (STAT3):” Michele Redell, M.D., Ph.D.Dr. Michele Redell, a pediatric oncologist with Texas Children’s Cancer Center and assistant professor of pediatrics at BCM, and Dr. Zachary Ball from Rice University were awarded $160,000 for their collaborative project to develop new drugs to treat acute myeloid leukemia (AML). Current treatment options, including chemotherapy and bone marrow transplants, are difficult and painful and relapses are common. Along with expertise provided by Dr. David Tweardy from Baylor College of Medicine, the team is looking at a new approach to create drugs that target the STAT3 protein which has been linked to aggressive growth of AML cells.
The Simmons Family Foundation created the Collaborative Research Fund with the goal of promoting novel solutions to difficult medical problems through the combined expertise of Texas Medical Center scientists, engineers and physicians who might not otherwise collaborate.
New Media Contact
Manager, Public Relations
About Texas Children’s Hospital
Texas Children’s Hospital is committed to a community of healthy children by providing the finest pediatric patient care, education and research. Renowned worldwide for its expertise and breakthrough developments in clinical care and research, Texas Children’s is nationally ranked in all 10 sub-specialties in U.S.News & World Report‘s list of Best Children’s Hospitals. Texas Children’s also operates the nation’s largest primary pediatric care network, with more than 40 offices throughout the greater Houston community. Texas Children’s has embarked on a $1.5 billion expansion, Vision 2010, which includes the Jan and Dan Duncan Neurological Research Institute, a comprehensive obstetrics facility focusing on high-risk births and a community hospital in suburban West Houston. For more information on Texas Children’s Hospital, go to www.texaschildrens.org. Get the latest news from Texas Children’s Hospital by visiting the online newsroom and on Twitter at www.twitter.com/texaschildrens.